Characterization of a new synthetic isoflavonoid with inverse agonist activity at the central benzodiazepine receptor

European Journal of Pharmacology

Volumn 495, Issue 2-3, 2004, Pages 87-96

  Lopes, Daniele V S ^a   Caruso, Rodrigo R B ^a   Castro, Newton G ^a   Costa, Paulo R R ^a   Da Silva, Alcides J M ^a   Noël, François ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Benzodiazepine; Coumestan; Flavonoid; Flunitrazepam; GABA

Indexed keywords

2 METHOXY 3,8,9 TRIHYDROXYCOUMESTAN; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUNITRAZEPAM; ISOFLAVONOID; MIDAZOLAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; IC 50; MALE; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC INHIBITION; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SCATCHARD PLOT;

EID: 3042798304     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.05.026     Document Type: Article

References (52)

1. A receptors in hippocampal neurons. Mol. Pharmacol. 59:2001;814-824
2. Bennett J.P. Jr. Methods in binding studies. Yamamura H.I., Enna S.J., Kuhar M.I. Neurotransmitter Receptor Binding. 1978;41-55 Raven Press, New York
3. Braestrup C., Schmiechen R., Neef G., Nielsen M., Petersen E.N. Interaction of convulsive ligands with benzodiazepine receptors. Science. 216:1982;1241-1243
4. Braestrup C., Honoré T., Nielsen M., Petersen E.N., Jensen L.H. Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem. Pharmacol. 33:1984;859-862
5. A receptors. J. Physiol. 497(Pt 3):1996;753-759
6. Brunig I., Scotti E., Sidler C., Fritschy J.M. Intact sorting, targeting, and clustering of γ-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J. Comp. Neurol. 443:2002;43-55
7. A receptors. Mol. Pharmacol. 63:2003;53-64
8. Castro N.G., de Mello M.C.F., de Mello F.G., Aracava Y. Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. Br. J. Pharmacol. 126:1999;1847-1855
9. Chambers M.S., Atack J.R., Broughton H.B., Collinson N., Cook S., Dawson G.R., Hobbs S.C., Marshall G., Maubach K.A., Pillai G.V., Reeve A.J., MacLeod A.M. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition. J. Med. Chem. 46:2003;2227-2240
10. Chebib M., Johnston G.A. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 43:2000;1427-1447
11. 3H] flunitrazepam binding to membrane-bound benzodiazepine receptors. Mol. Pharmacol. 21:1981;57-65
12. A receptors form clusters at GABAergic synapses in hippocampal cultures. NeuroReport. 13:2002;2355-2358
13. da Silva A.J., Melo P.A., Silva N.M., Brito F.V., Buarque C.D., de Souza D.V., Rodrigues V.P., Poças E.S., Noël F., Albuquerque E.X., Costa P.R. Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenation. Bioorg. Med. Chem. Lett. 11:2001;283-286
14. da Silva A.J., Buarque C.D., Brito F.V., Aurelian L., Macedo L.F., Malkas L.H., Hickey R.J., Lopes D.V., Noël F., Murakami Y.L., Silva N.M., Melo P.A., Caruso R.R., Castro N.G., Costa P.R. Synthesis and preliminary pharmacological evaluation of new (+/-) 1, 4-naphthoquinones structurally related to lapachol. Bioorg. Med. Chem. 10:2002;2731-2738
15. A receptor complex. J. Med. Chem. 42:1999;4343-4350
16. 2+ exchanger in GABAergic presynaptic boutons of rat central neurons. J. Neurophysiol. 87:2002;1694-1702
17. Eid C.N.J., Rose G.M. Cognition enhancement strategies by ion channel modulation of neurotransmission. Curr. Pharm. Des. 5:1999;345-361
18. Forster M.J., Prather P.L., Patel S.R., Lal H. The benzodiazepine receptor inverse agonist RO 15-3505 reverses recent memory deficits in aged mice. Pharmacol. Biochem. Behav. 51:1995;557-560
19. Gardner C.R., Tully W.R., Hedgecock C.J. The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog. Neurobiol. 40:1993;1-61
20. Gordon J.A. Anxiolytic drug targets: beyond the usual suspects. J. Clin. Invest. 110:2002;915-917
21. Goslin K., Banker G. Rat hippocampal neurons in low-density culture. Banker G., Goslin K. Culturing Nerve Cells. 1991;251 MIT Press, Cambridge
22. Hsu F.C., Waldeck R., Faber D.S., Smith S.S. Neurosteroid effects on GABAergic synaptic plasticity in hippocampus. J. Neurophysiol. 89:2003;1929-1940
23. A/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem. 43:2000;71-95
24. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol. 64:2002;1415-1424
25. A receptor. J. Med. Chem. 45:2002;4188-4201
26. Kaneda M., Farrant M., Cull-Candy S.G. Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum. J. Physiol. 485(Pt 2):1995;419-435
27. Kawasaki K., Eigyo M., Ikeda M., Kihara T., Koike K., Matsushita A., Murata S., Shiomi T., Takada S., Yasui M. A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 20:1996;1413-1425
28. A receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands. Ann. Med. 29:1997;275-282
29. A receptors. Prog. Neurobiol. 67:2002;113-159
30. Leão R.M., Mellor J.R., Randall A.D. Tonic benzodiazepine-sensitive GABAergic inhibition in cultured rodent cerebellar granule cells. Neuropharmacology. 39:2000;990-1003
31. A receptor complex. Bioorg. Med. Chem. 9:2001;323-335
32. A receptor subtype selective cognition enhancers. Curr. Drug Target CNS Neurol. Disord. 2:2003;233-239
33. Medina J.H., Paladini A.C., Wolfman C., Levi de Stein M., Calvo D., Diaz L.E., Peña C. Chrysin (5, 7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol. 40:1990;2227-2231
34. A receptor subtypes: a new pharmacology. Curr. Opin. Pharmacol. 1:2001;22-25
35. Möhler H., Fritschy J.M., Rudolph U. A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300:2002;2-8
36. Nielsen M., Frokjaer S., Braestrup C. High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem. Pharmacol. 37:1988;3285-3287
37. +-ATPase with an original mechanism of action. Biochem. Pharmacol. 66:2003;2169-2176
38. Rossi D.J., Hamann M., Attwell D. Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J. Physiol. 548:2003;97-110
39. A receptor subtypes. Nature. 401:1999;796-800
40. Salgueiro J.B., Ardenghi P., Dias M., Ferreira M.B., Izquierdo I., Medina J.H. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol. Biochem. Behav. 58:1997;887-891
41. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Brain Res. Rev. 23:1997;28-46
42. Silva C.L., Cruz H.N., Violante F.A., Cordeiro R.S., Martins M.A., Noel F. Formation of a highly stable complex between BN 50730 [tetrahydro-4, 7, 8, 10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4′, 3′-4, 5] thieno [3, 2-f] triazolo-1, 2, 4 [4, 3-a] diazepine-1, 4] and the platelet-activating factor receptor in rabbit platelet membranes. Biochem. Pharmacol. 51:1996;193-196
43. A conductances in hippocampal neurons. J. Neurosci. 22:2002;RC223
44. Trifiletti R.R., Snowman A.M., Snyder S.H. Barbiturate recognition site on the GABA/benzodiazepine receptor complex is distinct from the picrotoxinin/TBPS recognition site. Eur. J. Pharmacol. 106:1984;441-447
45. - channels are randomly activated by continuous GABA secretion in cultured embryonic rat hippocampal neurons. Neurosci. Lett. 155:1993;199-203
46. Viola H., Wolfman C., Levi de Stein M., Wasowski C., Peña C., Medina J.H., Paladini A.C. Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). J. Ethnopharmacol. 44:1994;47-53
47. Viola H., Marder M., Wasowski C., Giorgi O., Paladini A.C., Medina J.H. 6, 3′-dibromoflavone and 6-nitro-3′-bromoflavone: new additions to the 6, 3′-disubstituted flavone family of high-affinity ligands of the brain benzodiazepine binding site with agonistic properties. Biochem. Biophys. Res. Commun. 273:2000;694-698
48. A receptor modulators: in vitro-in vivo correlations. J. Pharmacol. Exp. Ther. 308:2003;88-101
49. A receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur. J. Neurosci. 9:1997;533-548
50. Whitehouse P.J. The cholinergic deficit in Alzheimer's disease. J. Clin. Psychiatry. 59(Suppl. 13):1998;19-22
51. Wolfman C., Viola H., Marder M., Ardenghi P., Wasowski C., Schröder N., Izquierdo I., Rúveda E., Paladini A., Medina J.H. Pharmacological characterization of 6-bromo-3′-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Pharmacol. Biochem. Behav. 61:1998;239-246
52. A receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol. Pharmacol. 63:2003;2-8